Gilead Sciences unveils campaign to help women fight cancer

The booth of Gilead Sciences at the fifth China International Import Expo in Shanghai on Nov 7, 2022. Gilead Sciences, a research-based biopharmaceutical company from California, launched a women's health advocacy campaign in China on Wednesday built around the idea of "taking back" the possibilities that cancer causes. Jin Fangqian, vice-president of Gilead Sciences and the group's general manager for China, said as an innovation-driven company, Gilead is not only committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer, but also striving to remedy health inequities and break down barriers to care. "By launching this campaign, we hope to further raise awareness of women's health in local society, enhance public understanding of breast cancer prevention and treatment, and help patients regain the possibilities in their lives," said Jin, adding the company will continue to invest in innovative research and development in the field of breast cancer and broader cancer types. By 2023, the company expanded into the oncology sector, introducing a new treatment option to China for patients with inoperable locally advanced or metastatic triple-negative breast cancer, offering innovative treatment option for those affected by this challenging condition.